Nicola Fusco, M.D.
Nicola Fusco, M.D.
European Institute of Oncology (IEO), University of Milan, Italy
Verified email at
Cited by
Cited by
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ...
Nature genetics 46 (11), 1166-1169, 2014
The genomic landscape of male breast cancers
S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ...
Clinical Cancer Research 22 (16), 4045-4056, 2016
MED12 somatic mutations in fibroadenomas and phyllodes tumors of the breast
S Piscuoglio, M Murray, N Fusco, C Marchiò, FL Loo, LG Martelotto, ...
Histopathology 67 (5), 719, 2015
Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer
G Valente, F Morani, G Nicotra, N Fusco, C Peracchio, R Titone, O Alabiso, ...
BioMed research international 2014, 2014
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer
N Fusco, FC Geyer, MR De Filippo, LG Martelotto, CKY Ng, S Piscuoglio, ...
Modern Pathology 29 (11), 1292-1305, 2016
HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions
N Fusco, EG Rocco, C Del Conte, C Pellegrini, G Bulfamante, F Di Nuovo, ...
Modern Pathology 26 (6), 816-824, 2013
Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations
E Guerini‐Rocco, S Piscuoglio, CKY Ng, FC Geyer, MR De Filippo, ...
The Journal of pathology 238 (5), 677-688, 2016
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study
E Guerini‐Rocco, Z Hodi, S Piscuoglio, CKY Ng, EA Rakha, ...
The Journal of pathology 237 (2), 166-178, 2015
Mismatch repair protein loss as a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability
N Fusco, G Lopez, C Corti, C Pesenti, P Colapietro, G Ercoli, G Gaudioso, ...
JNCI Cancer Spectrum 2 (4), pky056, 2018
Tackling the diversity of breast cancer related lymphedema: perspectives on diagnosis, risk assessment, and clinical management
A Michelotti, M Invernizzi, G Lopez, D Lorenzini, F Nesa, A De Sire, ...
The Breast 44, 15-23, 2019
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYBNFIB fusion gene
J Kim, FC Geyer, LG Martelotto, CKY Ng, RS Lim, P Selenica, A Li, ...
The Journal of pathology 244 (2), 143-150, 2018
Targeting immune-related biological processes in solid tumors: we do need biomarkers
F Pagni, E Guerini-Rocco, AM Schultheis, G Grazia, E Rijavec, M Ghidini, ...
International journal of molecular sciences 20 (21), 5452, 2019
HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
N Fusco, S Bosari
World journal of gastroenterology 22 (35), 7926, 2016
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study
A de Sire, A Baricich, F Renò, C Cisari, N Fusco, M Invernizzi
Aging clinical and experimental research 32 (5), 959-962, 2020
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases
L De Mattos-Arruda, CKY Ng, S Piscuoglio, M Gonzalez-Cao, RS Lim, ...
Oncotarget 9 (29), 20617, 2018
Therapeutic potential of immunoproteasome inhibition in Duchenne muscular dystrophy
A Farini, C Sitzia, B Cassani, L Cassinelli, R Rigoni, F Colleoni, N Fusco, ...
Molecular Therapy 24 (11), 1898-1912, 2016
Breast cancer systemic treatments and upper limb lymphedema: a risk-assessment platform encompassing tumor-specific pathological features reveals the potential role of trastuzumab
M Invernizzi, A Michelotti, M Noale, G Lopez, L Runza, M Giroda, ...
Journal of clinical medicine 8 (2), 138, 2019
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging
A Smith, M Galli, I Piga, V Denti, M Stella, C Chinello, N Fusco, D Leni, ...
Journal of proteomics 191, 114-123, 2019
Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild‐type classic polymorphous low‐grade adenocarcinomas of the salivary gland
S Piscuoglio, N Fusco, CKY Ng, LG Martelotto, A da Cruz Paula, N Katabi, ...
Histopathology 68 (7), 1055-1062, 2016
PTEN alterations and their role in cancer management: are we making headway on precision medicine?
N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, ...
Genes 11 (7), 719, 2020
The system can't perform the operation now. Try again later.
Articles 1–20